241 related articles for article (PubMed ID: 16121805)
1. Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder.
Jain S; Rajput A; Kumar Y; Uppuluri N; Arvind AS; Tatu U
J Assoc Physicians India; 2005 Jun; 53():513-20. PubMed ID: 16121805
[TBL] [Abstract][Full Text] [Related]
2. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
3. Increased urinary excretion of orosomucoid is a risk predictor of diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Liu H; Hou X; Cheng J
Nephrology (Carlton); 2009 Apr; 14(3):332-7. PubMed ID: 19143942
[TBL] [Abstract][Full Text] [Related]
4. Proteomic identification of urinary biomarkers of diabetic nephropathy.
Rao PV; Lu X; Standley M; Pattee P; Neelima G; Girisesh G; Dakshinamurthy KV; Roberts CT; Nagalla SR
Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332
[TBL] [Abstract][Full Text] [Related]
5. Effect of high dose thiamine on the levels of urinary protein biomarkers in diabetes mellitus type 2.
Riaz S; Skinner V; Srai SK
J Pharm Biomed Anal; 2011 Mar; 54(4):817-25. PubMed ID: 21130593
[TBL] [Abstract][Full Text] [Related]
6. Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis.
Meier M; Kaiser T; Herrmann A; Knueppel S; Hillmann M; Koester P; Danne T; Haller H; Fliser D; Mischak H
J Diabetes Complications; 2005; 19(4):223-32. PubMed ID: 15993357
[TBL] [Abstract][Full Text] [Related]
7. Alpha-1 microglobulin: a marker for early detection of tubular disorders in diabetic nephropathy.
Shore N; Khurshid R; Saleem M
J Ayub Med Coll Abbottabad; 2010; 22(4):53-5. PubMed ID: 22455261
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic strategy to monitor diabetic nephropathy.
Rowe DJ; Twyman S
Kidney Int Suppl; 1994 Nov; 47():S109-10. PubMed ID: 7869658
[TBL] [Abstract][Full Text] [Related]
9. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy.
Sharma K; Lee S; Han S; Lee S; Francos B; McCue P; Wassell R; Shaw MA; RamachandraRao SP
Proteomics; 2005 Jul; 5(10):2648-55. PubMed ID: 15984045
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis for the assessment of diabetic renal damage in humans.
Mischak H; Kaiser T; Walden M; Hillmann M; Wittke S; Herrmann A; Knueppel S; Haller H; Fliser D
Clin Sci (Lond); 2004 Nov; 107(5):485-95. PubMed ID: 15281910
[TBL] [Abstract][Full Text] [Related]
11. Proteomics and diabetic nephropathy.
Merchant ML; Klein JB
Semin Nephrol; 2007 Nov; 27(6):627-36. PubMed ID: 18061845
[TBL] [Abstract][Full Text] [Related]
12. Low molecular weight proteins in urines from healthy subjects as well as diabetic, nephropathic and diabetic-nephropathic patients: a MALDI study.
Lapolla A; Seraglia R; Molin L; Williams K; Cosma C; Reitano R; Sechi A; Ragazzi E; Traldi P
J Mass Spectrom; 2009 Mar; 44(3):419-25. PubMed ID: 19165811
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.
Yang YH; Zhang S; Cui JF; Lu B; Dong XH; Song XY; Liu YK; Zhu XX; Hu RM
Diabet Med; 2007 Dec; 24(12):1386-92. PubMed ID: 18042080
[TBL] [Abstract][Full Text] [Related]
14. A further investigation on a MALDI-based method for evaluation of markers of renal damage.
Lapolla A; Molin L; Sechi A; Cosma C; Ragazzi E; Seraglia R; Traldi P
J Mass Spectrom; 2009 Dec; 44(12):1754-60. PubMed ID: 19852035
[TBL] [Abstract][Full Text] [Related]
15. Proteomic techniques identify urine proteins that differentiate patients with interstitial cystitis from asymptomatic control subjects.
Canter MP; Graham CA; Heit MH; Blackwell LS; Wilkey DW; Klein JB; Merchant ML
Am J Obstet Gynecol; 2008 May; 198(5):553.e1-6. PubMed ID: 18455532
[TBL] [Abstract][Full Text] [Related]
16. Proteome analysis of serum from type 2 diabetics with nephropathy.
Kim HJ; Cho EH; Yoo JH; Kim PK; Shin JS; Kim MR; Kim CW
J Proteome Res; 2007 Feb; 6(2):735-43. PubMed ID: 17269729
[TBL] [Abstract][Full Text] [Related]
17. Utility of Albusure test in screening for early stage of diabetic nephropathy.
Zhang J; Lnoue K; Nakashima N; Hiramatsu S; Ohashi M; Umeda F; Nawata H
Chin Med J (Engl); 1994 Sep; 107(9):699-702. PubMed ID: 7805464
[TBL] [Abstract][Full Text] [Related]
18. [Revised criteria for the early diagnosis of diabetic nephropathy].
Inomat S; Haneda M; Moriya T; Katayama S; Iwamoto Y; Sakai H; Tomino Y; Matsuo S; Asano Y; Makino H;
Nihon Jinzo Gakkai Shi; 2005; 47(7):767-9. PubMed ID: 16296406
[TBL] [Abstract][Full Text] [Related]
19. Urinary proteome and potential biomarkers associated with serial pathogenesis steps of focal segmental glomerulosclerosis.
Shui HA; Huang TH; Ka SM; Chen PH; Lin YF; Chen A
Nephrol Dial Transplant; 2008 Jan; 23(1):176-85. PubMed ID: 17881425
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic strategies in urinalysis.
Hofmann W; Regenbogen C; Edel H; Guder WG
Kidney Int Suppl; 1994 Nov; 47():S111-4. PubMed ID: 7532739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
